Patents by Inventor Mike Farwick

Mike Farwick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9913789
    Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.
    Type: Grant
    Filed: July 1, 2014
    Date of Patent: March 13, 2018
    Assignee: Evonik Degussa GmbH
    Inventors: Tim Köhler, Mike Farwick, Matthias Mentel, Peter Lersch
  • Patent number: 9662515
    Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyric acid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyric acid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.
    Type: Grant
    Filed: July 20, 2012
    Date of Patent: May 30, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
  • Patent number: 9655934
    Abstract: The invention relates to a method for producing a dermatologically active yeast extract, comprising the following steps: providing a preculture of the yeast cells, culturing the cells for at least fifteen minutes at a pH of 1.8-4, harvesting the cells and lysing the cells, and a yeast extract produced thereby and products comprising said yeast extract.
    Type: Grant
    Filed: June 14, 2012
    Date of Patent: May 23, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Yvonne Schiemann, Mike Farwick, Thomas Haas, Mirja Wessel
  • Patent number: 9610232
    Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.
    Type: Grant
    Filed: July 4, 2012
    Date of Patent: April 4, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Mike Farwick, Tim Koehler, Matthias Mentel
  • Patent number: 9598711
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Grant
    Filed: June 27, 2016
    Date of Patent: March 21, 2017
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • Publication number: 20160304916
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Application
    Filed: June 27, 2016
    Publication date: October 20, 2016
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • Patent number: 9456973
    Abstract: The present invention relates to a cosmetic formulation comprising certain methionyl-methionine stereoisomers and to the use of methionyl-methionine for nail and/or hair treatment.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: October 4, 2016
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Mike Farwick, Matthias Mentel, Ursula Maczkiewitz, Andreas Seifert
  • Patent number: 9404118
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Grant
    Filed: July 23, 2012
    Date of Patent: August 2, 2016
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • Patent number: 9388439
    Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: July 12, 2016
    Assignee: EVONIK DEGUSSA GMBH
    Inventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
  • Publication number: 20160184204
    Abstract: The present invention relates to formulations comprising A) sphinganine and B) at least one active ingredient selected from the group creatine, creatinine, caffeine, carnitine, biotin, arjunolic acid, xymenynic acid, minoxidil, arginine and derivatives thereof.
    Type: Application
    Filed: July 1, 2014
    Publication date: June 30, 2016
    Applicant: Evonik Degussa GmbH
    Inventors: Tim KÖHLER, Mike FARWICK, Matthias MENTEL, Peter LERSCH
  • Patent number: 9109051
    Abstract: The present invention relates to methods of producing crosslinked hyaluronic acid microbeads, as well as the produced microbeads, said method comprising the steps of: (a) providing an aqueous alkaline solution comprising hyaluronic acid, or a salt thereof; (b) forming microdroplets having a desired size from the mixed solution of step (a) in an organic or oil phase to form a water in organic or water in oil (VWO) emulsion, wherein the amount of oil phase used is of from 20 to less than 50% by weight based on the sum of oil phase and water; (c) adding a solution comprising a crosslinking agent to the emulsion, whereby the reaction of hyaluronic acid with the crosslinking agent takes place to provide crosslinked hyaluronic acid microbeads; and (d) optionally working up the dispersion of crosslinked hyaluronic acid microbeads obtained in step (c).
    Type: Grant
    Filed: December 10, 2008
    Date of Patent: August 18, 2015
    Assignees: EVONIK GOLDSCHMIDT GMBH, NOVOZYMES BIOPOLYMER A/S
    Inventors: Hans Henning Wenk, Mike Farwick, Sandra Nattland, Ursula Maczkiewitz, Birgitte Moelholm Malle
  • Publication number: 20150118721
    Abstract: The invention relates to novel enzymes that provide acetylated sphingoid bases.
    Type: Application
    Filed: March 13, 2013
    Publication date: April 30, 2015
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Steffen Schaffer, Mike Farwick, Heiko Andrea, Tim Koehler, Daniel Wolff, Frank ter Veld, Ansgar Poetsch, Eckhard Boles, Christoph Schorsch
  • Publication number: 20150118173
    Abstract: The invention relates to a formulation comprising caprylic acid ethanolamide and/or capric acid ethanolamide in combination with an aluminium salt and to its use.
    Type: Application
    Filed: March 28, 2013
    Publication date: April 30, 2015
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Mike Farwick, Oliver Springer, Matthias Mentel, Stefan Bergfried
  • Publication number: 20150044158
    Abstract: The present invention relates to a cosmetic formulation comprising certain methionyl-methionine stereoisomers and to the use of methionyl-methionine for nail and/or hair treatment.
    Type: Application
    Filed: August 6, 2014
    Publication date: February 12, 2015
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Mike FARWICK, Matthias MENTEL, Ursula MACZKIEWITZ, Andreas SEIFERT
  • Publication number: 20140342025
    Abstract: The invention relates to the use of arjunolic acid for increasing sebum production, and to preparations comprising arjunolic acid and 1,2-pentanediol.
    Type: Application
    Filed: October 5, 2012
    Publication date: November 20, 2014
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Mike Farwick, Benjamin Tuchscherer, Matthias Mentel
  • Publication number: 20140308310
    Abstract: The invention relates to a process for the production of 4-aminobutyric acid, also referred to as gamma-aminobutyric acid, in short GABA, to a process for the production of an extract comprising 4-aminobutyricacid, to a process for the preparation of a cosmetic formulation comprising 4-aminobutyricacid, and to the use of Cyanidium caldarium cells or cell components in cosmetic applications.
    Type: Application
    Filed: July 20, 2012
    Publication date: October 16, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Jennifer Schild, Matthias Mentel, Peter Lersch, Mike Farwick, Christian Weitemeyer
  • Publication number: 20140309309
    Abstract: The invention relates to a cosmetic formulation and to its use.
    Type: Application
    Filed: October 23, 2012
    Publication date: October 16, 2014
    Applicant: EVONIK INDUSTRIES AG
    Inventors: Mike Farwick, Matthias Mentel, Tim Köhler
  • Publication number: 20140199736
    Abstract: The invention relates to genetically modified Pichia ciferrii cells, to the use thereof and to a method of producing sphingoid bases and sphingolipids.
    Type: Application
    Filed: July 23, 2012
    Publication date: July 17, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Tim Köhler, Christoph Schorsch, Eckhard Boles, Heiko Andrea, Mike Farwick, Steffen Schaffer
  • Publication number: 20140170092
    Abstract: The invention relates to the use of sphinganine for improving the visual appearance of skin and hair, for caring for, for protecting and/or for stimulating the growth of skin and hair.
    Type: Application
    Filed: July 4, 2012
    Publication date: June 19, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Mike Farwick, Tim Koehler, Matthias Mentel
  • Publication number: 20140127257
    Abstract: The invention relates to a method for producing a dermatologically active yeast extract, comprising the following steps: providing a preculture of the yeast cells, culturing the cells for at least fifteen minutes at a pH of 1.8-4, harvesting the cells and lysing the cells, and a yeast extract produced thereby and products comprising said yeast extract.
    Type: Application
    Filed: June 14, 2012
    Publication date: May 8, 2014
    Applicant: EVONIK DEGUSSA GMBH
    Inventors: Yvonne Schiemann, Mike Farwick, Thomas Haas, Mirja Wessel